Biogen-Idec promotional activities

Biogen Idec the pharma company that markets Avonex (interferon-beta-1a) and Tysabri (natalizumab) put out a statement on Friday that state and federal authorities in the United States are investigating its sales and promotional practices.The company disclosed the investigation in an annual report filed Friday with the U.S. Securities and Exchange Commission.


Source: Nasdaq

"Let's hope this is not another case of Pharma behaving badly; every time it occurs the fall-out is massive. MS'ers and MS healthcare professionals don't need another scandal! Confidence in Industry, and with Neurologists linked with industry, is already at an all-time low."

Labels: